Human Herpesvirus 6 Infection as a Trigger of Multiple Sclerosis

Voumvourakis, Konstantine I.; Kitsos, Dimitrios K.; Tsiodras, Sotirios; Petrikkos, George; Stamboulis, Eleftherios
November 2010
Mayo Clinic Proceedings;Nov2010, Vol. 85 Issue 11, p1023
Academic Journal
We systematically reviewed the existing evidence to determine whether a relationship exists between infection with human herpesvirus 6 (HHV-6) and multiple sclerosis(MS) and, if so, to define the strength of that relationship. The following terms were used in searches of the Entrez-PubMed database (1966-2009): human herpes virus 6, HHV 6, demyelination, multiple sclerosis, pathogenesis, diagnosis, serology, cerebrospinal fluid, IgG antibodies, IgM antibodies. PCR, and lymphoproliferative techniques. Study quality was assessed using the criteria proposed by Moore and Wolfson and by the classification criteria used by the Canadian Task Force on the Periodic Health Examination. Studies were categorized both by experimental technique and by quality (high [A], intermediate [B], and low [C]) as determined by the Moore and Wolfson criteria. Overall, 25 (41%) of 61 studies, 15 (60%) of which were classified as A quality, reached a statistically significant result. According to the Canadian Task Force classification, all studies were categorized as evidence of quality II-1. Limitations of the available experimental techniques and perspectives for future research are discussed. The current review supports the need for further, objective, evidence-based examination of the relationship between HHV-6 infection and multiple sclerosis.


Related Articles

  • Human herpes virus 6 and multiple sclerosis: a Finnish twin study. Kuusisto, H.; Hy�ty, H.; Kares, S.; Kinnunen, E.; Elovaara, I. // Multiple Sclerosis (13524585);Jan2008, Vol. 14 Issue 1, p54 

    Objective To investigate the possible association of human herpes virus 6- (HHV6) infection and multiple sclerosis (MS). Background Despite intensive investigations of genetic and environmental factors, the etiopathogenesis of MS remains unknown. HHV6 is a possible candidate in that it is...

  • A comparative audit of anticardiolipin antibodies in oligoclonal band negative and positive multiple sclerosis. Vilisaar, Janek; Wilson, Martin; Niepel, Graham; Blumhardt, Lance D; Constantinescu, Cris S // Multiple Sclerosis (13524585);Aug2005, Vol. 11 Issue 4, p378 

    It has been suggested that multiple sclerosis (MS) patients with positive anticardiolipin antibodies (ACLA) have some atypical features, including absent oligoclonal bands (OCB) in the cerebrospinal fluid (CSF). Our aim was to compare the frequencies of ACLA and related laboratory and clinical...

  • CSF POLYSPECIFIC ANTIBODY RESPONSE IN MULTIPLE SCLEROSIS. Robinson-Agramonte, María de los Angeles; Reiber, Hansotto; Dorta-Contreras, Alberto J. // Revista VacciMonitor (Vacunología y Temas Afines);Oct2002, Vol. 11 Issue 4, p1 

    The intrathecal response of IgG, is the most frequent neuropathological sign in Multiple Sclerosis patients beside the detection of oligoclonal IgG bands in cerebrospinal fluid. At the same time the observation of an intrathecal antibody synthesis (Antibody Index, AI>1.4) against neurotropic...

  • Cerebrospinal fluid in multiple sclerosis. Rammohan, Kottil W. // Annals of Indian Academy of Neurology;Oct-Dec2009, Vol. 12 Issue 4, p246 

    Background: Technological advances have made it possible to examine the human cerebrospinal fluid (CSF) in a manner that was previously impossible. CSF provides a window into the changes that occur in the central nervous system (CNS) in health and disease. Through analysis of the CSF, we discern...

  • Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis. Pisa, D.; Alonso, R.; Jiménez-Jiménez, F.; Carrasco, L. // European Journal of Clinical Microbiology & Infectious Diseases;Jun2013, Vol. 32 Issue 6, p795 

    Multiple sclerosis (MS) is the prototypical inflammatory disease of the central nervous system and spinal cord, leading to axonal demyelination of neurons. Recently, we have found a correlation between fungal infection and MS in peripheral blood of patients. The present work provides evidence of...

  • Multiple sclerosis: use of light-chain typing to assist diagnosis. Jenkins, Margaret A.; Louisa Cheng; Ratnaike, Sujiva // Annals of Clinical Biochemistry;May2001, Vol. 38 Issue 3, p235 

    Although the presence of oligoclonal IgG with abnormal ratio in multiple sclerosis (MS) has been known for many years, this finding has not been put to diagnostic use in most routine clinical laboratories. In a retrospective study we report differences in the oligoclonal banding patterns between...

  • Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis. Brettschneider, J.; Maier, M.; Arda, S.; Claus, A.; S�ssmuth, S. D.; Kassubek, J.; Tumani, H. // Multiple Sclerosis (13524585);Jun2005, Vol. 11 Issue 3, p261 

    Axonal damage has been proposed as the major substrate of permanent clinical disability in multiple sclerosis. Tau protein, a microtubule-associated protein localised in neuronal axons, may serve as a biochemical surrogate marker to evaluate axonal damage in vivo. We intended to determine the...

  • Cerebrospinal fluid proteome profile in multiple sclerosis. Lehmensiek, V.; Süssmuth, S. D.; Tauscher, G.; Brettschneider, J.; Felk, S.; Gillardon, F.; Tumani, H. // Multiple Sclerosis (13524585);Aug2007, Vol. 13 Issue 7, p840 

    Cerebrospinal fluid (CSF) proteins may provide important information about the pathomechanisms present in multiple sclerosis (MS). Although diagnostic criteria for early MS are available, there is still a need for biomarkers, predicting disease subtype and progression to improve individually...

  • Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study. Leone, M. A.; Bonissoni, S.; Collimedaglia, L.; Tesser, F.; Calzoni, S.; Stecco, A.; Naldi, P.; Monaco, F. // Multiple Sclerosis (13524585);May2008, Vol. 14 Issue 4, p485 

    Objective To prospectively evaluate predictors of incomplete recovery after the first attacks in a cohort of patients with clinically isolated syndrome or relapsing-remitting multiple sclerosis. Methods Seventy-two consecutive patients recruited from January 2001 to December 2003, evaluated...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics